G

GlycoMimetics
D

GLYC

0.21600
USD
-0.02
(-8.05%)
مفتوح الان
حجم التداول
917
الربح لكل سهم
-1
العائد الربحي
-
P/E
-0
حجم السوق
13,928,535
أصول ذات صلة
    ALNY
    ALNY
    -5.995
    (-2.44%)
    239.510 USD
    C
    CRBP
    -0.020
    (-0.15%)
    12.940 USD
    F
    FIXX
    0
    (0%)
    0.000000 USD
    G
    GLMD
    -0.14000
    (-4.42%)
    3.03000 USD
    G
    GLYC
    -0.01890
    (-8.05%)
    0.21600 USD
    P
    PRQR
    -0.02500
    (-0.95%)
    2.62000 USD
    R
    RGNX
    -0.30000
    (-3.93%)
    7.33000 USD
    VRTX
    VRTX
    2.49
    (0.63%)
    400.64 USD
    المزيد
الأخبار

العنوان: GlycoMimetics

القطاع: Healthcare
الصناعة: Biotechnology
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.